日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Novel Pyridone Carboxamide Derived Compounds as Soluble Epoxide Hydrolase Inhibitors for Treating Diabetic Retinopathy

新型吡啶酮羧酰胺衍生物作为可溶性环氧化物水解酶抑制剂用于治疗糖尿病视网膜病变

Sabnis, Ram W

Novel Compounds for Treating Huntington's Disease

用于治疗亨廷顿病的新型化合物

Sabnis, Ram W; Sabnis, Anika R

Novel Indazole Compounds as PKMYT1 Kinase Inhibitors for Treating Cancer

新型吲唑化合物作为PKMYT1激酶抑制剂用于治疗癌症

Sabnis, Ram W

Novel Compounds for Treating Hemoglobinopathies, Namely, Anemia, Sickle Cell Disease, or Thalassemia

用于治疗血红蛋白病(即贫血、镰状细胞病或地中海贫血)的新型化合物

Sabnis, Ram W

Novel Compounds as Glucagon-Like Peptide‑1 Receptor Agonists for Treating Diabetes

新型化合物作为胰高血糖素样肽-1受体激动剂用于治疗糖尿病

Sabnis, Ram W

Novel Pyrrolopyridine Compounds as 5-HT2A Agonists for Treating Mental Illnesses

新型吡咯并吡啶化合物作为5-HT2A受体激动剂治疗精神疾病

Sabnis, Ram W; Sabnis, Anika R

Novel Compounds as 5-HT2A Agonists for Treating Mental Illness or CNS Disorders

新型化合物作为5-HT2A激动剂用于治疗精神疾病或中枢神经系统疾病

Sabnis, Ram W; Sabnis, Anika R

Novel Compounds as 5-HT2A Receptor Modulators for Treating Psychiatric and Neurological Disorders

新型化合物作为5-HT2A受体调节剂用于治疗精神和神经系统疾病

Sabnis, Ram W; Sabnis, Anika R

Novel 1,6-Naphthridine Compounds as SMARCA2 Inhibitors for Treating Non-small Cell Lung Cancer

新型1,6-萘啶类化合物作为SMARCA2抑制剂用于治疗非小细胞肺癌

Sabnis, Ram W

1,6-Naphthridine Compounds as SMARCA2 Inhibitors for Treating Non-small Cell Lung Cancer

1,6-萘啶类化合物作为SMARCA2抑制剂用于治疗非小细胞肺癌

Sabnis, Ram W